Is kidney function altered by the duration of cardiopulmonary bypass?

Slides:

Advertisements

Similar presentations

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

Advertisements

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Time course of cranial ultrasound abnormalities after arterial switch operation in neonates Matthias Sigler, MD, Jaime F Vazquez-Jimenez, MD, Ralph G.

Risk Index for Postoperative Acute Kidney Injury After Valvular Surgery Using Cardiopulmonary Bypass Takashi Yamauchi, MD, PhD, Shigeru Miyagawa, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Beating heart operations including hybrid revascularization: initial experiences Friedrich-Christian Riess, MD, Joachim Schofer, MD, Peter Kremer, MD,

Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer Shenhai Wei, MD, PhD,

Acute Kidney Injury: A Relevant Complication After Cardiac Surgery

Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD

Regional low-flow perfusion provides somatic circulatory support during neonatal aortic arch surgery Frank A Pigula, MD, Sanjiv K Gandhi, MD, Ralph D.

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

James L Zellner, MD, Scott B Kribbs, BS, B

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Assessment of heparin anticoagulation: comparison of two commercially available methods Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Hyperoxia for management of acid-base status during deep hypothermia with circulatory arrest Jeffrey M Pearl, MD, Donald W Thomas, Gary Grist, Jodie.

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Oxidative Stress and Atrial Fibrillation After Cardiac Surgery: A Case-Control Study Basel Ramlawi, MD, MMSc, Hasan Otu, PhD, Shigetoshi Mieno, MD, Munir.

The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting Stephen R Hazelrigg, MD, Theresa M Boley,

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Delayed Presentation of Nitroprusside-Induced Cyanide Toxicity

Relationship Between Antiinflammatory Cytokine Interleukin-10 and Lactate Concentrations in Neonates Undergoing the Arterial Switch Operation Kyrylo.

Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction

Acute Kidney Injury and Hemodilution During Cardiopulmonary Bypass: A Changing Scenario Marco Ranucci, MD, FESC, Tommaso Aloisio, MD, Giovanni Carboni,

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure Eric Berreklouw, MD, PhD, Frank Bracke, MD, Albert Meijer, MD, PhD, Kathinka.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Oxygen Delivery During Cardiopulmonary Bypass and Acute Renal Failure After Coronary Operations Marco Ranucci, MD, Federica Romitti, MD, Giuseppe Isgrò,

Minimized Cardiopulmonary Bypass Reduces Retinal Microembolization: A Randomized Clinical Study Using Fluorescein Angiography Riikka Rimpiläinen, MD,

Hannu J Penttilä, MD, Martti V

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

On-pump versus off-pump coronary revascularization: evaluation of renal function Raimondo Ascione, MD, Clinton T Lloyd, Malcom J Underwood, Walter J Gomes,

Cassandra Joffs, MD, Himali R. Gunasinghe, BS, Marlina M

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Mudassir I Dar, Timothy Gillott, Franco Ciulli, MD, Graham J Cooper

Vacuum-Assisted Closure for the Treatment of Complex Chest Wounds

Safety and efficacy of a heparin removal device: a prospective randomized preclinical outcomes study Joseph B Zwischenberger, MD, Weike Tao, MD, Donald.

Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass Nobuhiko Hayashida, MD, PhD, Hiroshi Tomoeda, MD, Takeshi Oda, MD,

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Christian Olsson, MD, Agneta Siegbahn, MD, PhD,

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Olaf Reinhartz, MD, Anil M DeSilva, MD, Frank L Hanley, MD

Serum Cystatin C in Elderly Cardiac Surgery Patients

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Valvular heart operation is an independent risk factor for acute renal failure Antony D Grayson, Magdy Khater, FRCA, Mark Jackson, PhD, Mark A Fox, FRCA

Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG Jan T. Christenson, MD, PhD, Pierre Badel, MD,

Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.

Neal S Goldstein, MD The Annals of Thoracic Surgery

Fraser D. Rubens, MD, MS, Gilbert Lavalee, Marc A

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Sérgio A de Oliveira, MD The Annals of Thoracic Surgery

Short-term neuropsychologic differences after normothermic versus hypothermic cardiopulmonary bypass Dagmar Buschbeck, Friedrich-Christian Riess, MD,

Joachim Boldt, Bernd Kumle, Michael Papsdorf, Gunter Hempelmann

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery Colin Royse, MBBS, MD, Alistair Royse, MBBS, MD,

Factors influencing intensive care unit length of stay after surgery for acute aortic dissection type A Daniel Hoefer, MD, Elfriede Ruttmann, MD, Markus.

Pulmonary artery banding before Norwood procedure

Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations Martin Misfeld, MD, Sven Dubbert, Sawas Eleftheriadis,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Christine S Rinder, MD, Manuel Fontes, MD,

Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

Stephen Greer, MD, Ashley D. Miller, FNP, Jeremiah S

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Presentation transcript:

Is kidney function altered by the duration of cardiopulmonary bypass? Joachim Boldt, MD, PhD, Torsten Brenner, Andreas Lehmann, MD, Stephan W Suttner, MD, Bernhard Kumle, MD, Frank Isgro, MD The Annals of Thoracic Surgery Volume 75, Issue 3, Pages 906-912 (March 2003) DOI: 10.1016/S0003-4975(02)04559-9

Fig 1 Changes in (A) creatinine clearance (normal value, 70 to 110 mL/min) and (B) fractional excretion of sodium (normal value, < 1%) in the two groups. +p less than 0.05 different to baseline data; *p less than 0.05 different to the other group; dashed line indicates normal range. (CPB = cardiopulmonary bypass; POD = postoperative day.) The Annals of Thoracic Surgery 2003 75, 906-912DOI: (10.1016/S0003-4975(02)04559-9)

Fig 2 Changes in (A) N-acetyl-β-D-glucosaminidase (normal value, 0 to 7 U/L) and (B) α1-microglobulin (normal value, < 14 mg/L) in the two groups. +p less than 0.05 different to baseline data; *p less than 0.05 different to the other group; dashed lines indicate normal range. (CPB = cardiopulmonary bypass; POD = postoperative day.) The Annals of Thoracic Surgery 2003 75, 906-912DOI: (10.1016/S0003-4975(02)04559-9)

Fig 3 Changes in (A) glutathione transferase-π creatinine clearance (normal value, 12 to 15 μg/L) and (B) glutathione transferase-α (normal value, 3.5 ± 11.1 μg/L) in the two groups. +p less than 0.05 different to baseline data; *p less than 0.05 different to the other group; dashed lines indicate normal range. (CPB = cardiopulmonary bypass; POD = postoperative day.) The Annals of Thoracic Surgery 2003 75, 906-912DOI: (10.1016/S0003-4975(02)04559-9)